> For example, pharmaceutical companies currently create cancer antibodies in expensive hamster ovary cells that do not often misfold proteins. The ability to quickly and cheaply re-form common proteins from yeast or E. coli bacteria could potentially streamline protein manufacturing and make cancer treatments more affordable.
That is not saying research. That is quite explicitly claiming lower price of manufacture will result in cheaper cancer treatments.
It will result in cancer treatments that are cheaper to produce.
This does not mean the treatments will be more widely available, not that they will be cheaper.
Remember that drugs useful for cancer treatment in the USA are already orders of magnitude more expensive than non-US products simply because they can be.
Cute that this article believes the price of biologics for cancer treatment is in any way related to the price of manufacture.